(Date:11/5/2009)...HA, Neb., Nov. 5 Transge...nced financial results for the quarter ended Septe... presented in the tables that follow. ,, Third...ss of $366,000 or $0.01 per share for the third qu...0 or $0.01 per share for the third quarter of 2008...
(Date:11/5/2009)...MONT, Calif., Nov. 5 Waf... a leading developer of state-of-the-art genetic a...Sears, Ph.D. has joined the company,s Scientific A...igning and commercializing novel molecular diagnos...and on the development of computational biology sy...
(Date:11/5/2009)... Brooke Sanders brings a new look ... (PRWEB) November 5, 2009 -- Professional Reprogra...graphics company is pleased to present Brooke Sand...eir graphics/PR specialist. The addition of Brooke...t growth within Professional Reprographics., , ,Br...
(Date:11/4/2009)... ,, ROCKVILLE, Md., Nov. 4 Zyng...ny focused on next-generation antibody drug develo...lion in Series A funding from New Enterprise Assoc...pital firms. The capital will be used to create no...ddress two or more biological targets with a singl...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4Zyngenia, Inc. Raises $10 Million in Series A Funding 2Zyngenia, Inc. Raises $10 Million in Series A Funding 3Zyngenia, Inc. Raises $10 Million in Series A Funding 4...AMSTERDAM, The Netherlands, August 5 ,Amsterdam Mo...the field of,human gene therapy, today announced t...first half year of 2008 on Wednesday, August 13, 2...s these results, the company,will conduct a confer...800-949-4517 (toll free); US dial in: +1-866-291-4...
..., Scientists at the U.S. Department of Energy,s L...rsity of California at Berkeley have created the w...n nanowire arrays, combining light sensors and ele...Their method can be used to reproduce numerous suc... made with specific chemical, electronic, and othe...
...VALENCIA, Calif., Aug. 4 MannKind Corporation,(Na... financial results on,Monday, August 11, 2008 at 4...t a conference call to discuss the,second quarter ...pany,developments at 5:00 p.m. EDT on Monday, Augu...ts Chairman and Chief Executive Officer, Alfred Ma...
Other Biology Technology:A first in integrated nanowire sensor circuitry 2A first in integrated nanowire sensor circuitry 3A first in integrated nanowire sensor circuitry 4MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008 2Sma I (High Concentration) from Takara Mirus Bio
BamH I from New England Biolabs
Rabbit Anti-Leptin Receptor Polyclonal Antibody, Unconjugated from BioVision
Expand 20 kb PLUS PCR System; Thermostable DNA polymerase mixture from Roche Applied Science
Biology Products: